WELCOME TO The chemical REPORT
Project Design Engineers Ltd
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
PRODUCTS AND TECHNOLOGIES
Navigator CO2 , OCI N.V. | November 29, 2021
Navigator CO2 Ventures LLC (”Navigator”) announced today that it has entered into an agreement with OCI N.V.’s wholly-owned Iowa Fertilizer Company facility (“OCI”) to provide CO2 transportation and storage services on its carbon capture and storage system, the Heartland Greenway.
The project is backed by BlackRock’s Global Energy & Power Infrastructure Fund III, which invests in essential, long-term infrastructure assets, and is commerciall...
Chemicalwatch | May 06, 2020
The new chair of a UK parliamentary committee has expressed his concerns over the government's post-Brexit chemicals strategy, after its development was suspended due to the coronavirus Covid-19 pandemic. In a letter to minister of state George Eustice, Environmental Audit Committee chair Philip Dunne said that given the delays already incurred, the decision to pause work on it in order to prioritise the government's response to the pandemic was "regrettable". The Department fo...
EHS Daily Advisor | February 03, 2020
The authority of the U.S. Chemical Safety and Hazard Investigation Board (CSB) to subpoena information relating to potential future risks was affirmed by a panel of judges with the U.S. Court of Appeals for the 9th Circuit. The defendant in the case had contended that the CSB’s subpoena authority was limited to information about the cause or probable cause of an accidental chemical release that occurred in 2015, not about any event that hasn’t happened. A U.S. District Court judge ag...
Baylor College of Medicine | July 10, 2020
Scientists at Baylor College of Medicine have devised a chemical approach for discovering new enzyme-binding compounds that could be developed into drugs for various illnesses and conditions. This process can be used to support development of novel antiviral drugs for use in the continuing COVID-19 pandemic.
The study, published online today in the Proceedings of the National Academy of Sciences USA, was co-led by Dr. Surendra Dawadi, instructor in the Center for Drug Discovery at...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE